Joshua Szczepanski

WRT 160 Annotated Bibliography 28 October 2012

Bartella, L., & Morris, E. A. (2006). Advances in Breast Imaging: Magnetic Resonance Imaging. Current Oncology Reports, 7-13. In the article Advances in Breast Imaging: Magnetic Resonance Imaging, the current and evolving trends for cancer detection in breast MRI are addressed (Bartella & Morris, 2006). These trends include Preoperative Staging, Neoadjuvant Chemotherapy Response, Assessment of Residual Disease, Tumor Recurrence at the Lumpectomy site, Occult Primary Breast Cancer, High-Risk Screening, and Magnetic Resonance Spectroscopy. Preoperative Staging involves the detection and planning for breast cancer. Magnetic Resonance Imaging can also be used to monitor the response to neoadjuvant chemotherapy (Bartella & Morris, 2006). A MRI can also help to predict which patients are responding to neoadjuvant chemotherapy. After a patient has undergone lumpectomy, a MRI is often used in the assessment of residual tumor load (Bartella & Morris, 2006). This article also reveals the helpfulness of an MRI in screening of high-risk patients and patients with suspicious occult primary breast cancer. Griebsch et al., I. (2006). Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. British Journal of Cancer, 801-810.

Griebschs article focuses on the how cost-effective enhanced magnetic resonance imaging is for women, especially those who have a high familial risk of breast cancer (Griebsch et al., 2006). The study compares the costs of receiving a mammogram, an MRI, and the two combined, and then factors in the efficiency of each to their ability to detect a cancerous mass. The study suggests that the addition of CE MRI to a program for high familial risk women for breast cancer might be cost-effective (Griebsch et al., 2006). The article also discusses some psychological effects of an annual program similar to what they suggested. Tozaki, M. (2008). Diagnosis of breast cancer: MDCT versus MRI. Breast Cancer, 205-211. Mitsuhiro Tozakis article is about using multidetector CT scans versus magnetic resonance imaging. Due to its increasing commercial availability in recent years, multidetector CT scans have been used quite often. When comparing mammograms and ultrasounds to a multidetector CT, the CT scan is useful for pre-surgical assessments of breast-conserving surgery (Tozaki, 2008). Meanwhile, magnetic resonance imaging is tremendously helpful in the diagnosis of intraductal carcinoma and multicentricity of breast cancer (Tozaki, 2008). The problem is the amount of x-ray exposure a patient receives during a multidetector CT, which makes its use controversial. Plana, M. N., Carreira, C., Muriel, A., Chiva, M., Abraira, V., Emparanza, J. I., . . . Zamora, J. (2012). Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. European Radiology, 26-38.

The next article serves the purpose of estimating the diagnostic accuracy of magnetic resonance imaging. The study tested the accuracy in detecting lesions and contralateral cancer that was not identified when traditional techniques were used (Plana, et al., 2012). The accuracy of magnetic resonance imaging in this context has been studied before, but the results have varied. Despite these varying results, magnetic resonance imaging is still thought to be more effective than mammograms, ultrasounds, and clinical examinations (Plana, et al., 2012). This study finds that preoperative magnetic resonance imaging encouraged more extensive surgery, however the long-term impact of clinically relevant outcomes has not yet been demonstrated (Plana, et al., 2012). Ikeda, D. M., Baker, D. R., & Daneil, B. L. (2000). Magnetic Resonance Imaging of Breast Cancer: Clinical Indications and Breast MRI Reporting System. Journal of Magnetic Resonance Imaging, 975-983. Ikeda, Baker, and Daniel focus their article on clinical indications and breast magnetic resonance imaging reporting systems. The article discusses MRI in evaluation of mammographically-detected lesions, high-risk screening, preoperative breast cancer staging, evaluation for breast cancer recurrence, localization of primary breast cancer, and evaluation of the breast after neoadjuvant chemotherapy (Ikeda, Baker, & Daneil, 2000). The topics of this article are very similar to those of the article written by Bartella and Morris. Ikeda, Baker, and Daniel add suggestions about the standardization of breast MRI reporting. According to them, standardization of terms is required to compare MRI publication results and to provide insight

into the commonly seen findings (Ikeda, Baker, & Daneil, 2000). This will allow the imaging reports to be easily and more accurately reproduced.